Survival of patients with KRAS wild-type metastatic colorectal cancer is identical after sequential treatment with cetuximab and bevacizumab regardless of the sequence – A retrospective single-center study

Objective: To investigate the overall survival of patients with KRAS wild-type metastatic colorectal cancer (mCRC) after sequentially receiving both bevacizumab and cetuximab during the course of treatment. Methods: Twenty-six mCRC patients who received both bevacizumab and cetuximab at the Sun Yat-...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Gastroenterol Rep (Oxf)
Main Authors: Deng, Yanhong, Cai, Yue, Lin, Jiayu, Jiang, Ling, Hu, Huabin
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2015
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4650979/
https://ncbi.nlm.nih.gov/pubmed/26468218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gastro/gov051
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker